In recent weeks, the cryptocurrency market has witnessed significant fluctuations, particularly in the realm of corporate Bitcoin investments. Michael Saylor’s Strategy, recognized as one of the largest corporate Bitcoin investors globally, has recently slowed its acquisition of BTC amid a brief surge in cryptocurrency prices.
During the week spanning April 28 to May 4, Strategy purchased 1,895 Bitcoins for $180.3 million, averaging $95,167 per Bitcoin. This transaction was disclosed in the firm’s latest Form-8 filing with the U.S. Securities and Exchange Commission. Notably, this recent purchase marks one of the smallest acquisitions made by Strategy this year, following a relatively modest 130 BTC purchase in March.
The scale of this latest buy is a stark contrast to Strategy’s previous acquisition of 15,355 BTC announced just a week prior, which highlights a notable shift in their investment patterns.
Semler Scientific Increases BTC Acquisitions Despite Price Rises
While Strategy has chosen to ease its buying activity, other companies are demonstrating a heightened appetite for Bitcoin. Semler Scientific, a U.S.-based healthtech firm, has made headlines with its active investment strategy. From April 30 to May 2, Semler acquired 167 BTC for $16.2 million at an average price of $97,093 per Bitcoin, marking a 50% increase from a prior purchase of 111 BTC announced on April 25.
As of May 2, 2025, Semler’s total Bitcoin holdings stand at 3,634 BTC, accumulated for a total expenditure of $322.3 million, averaging $88,668 per Bitcoin. Although Semler’s holdings are significantly smaller than those of Strategy, which now holds a total of 555,450 BTC at an average purchase price of $68,550 per BTC, their proactive approach showcases a divergent strategy amidst market volatility.
This evolving landscape illustrates the diverse strategies undertaken by corporations in navigating the cryptocurrency market. As businesses continue to adapt their approaches, the ongoing shifts in Bitcoin acquisitions will undoubtedly be a focal point for investors and analysts alike.
This is a developing story, and further information will be added as it becomes available.
